LUND, Sweden--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutical AB (publ) (STO:NVP), the mitochondrial medicine company, announces the presentation of preclinical data from its Complex I deficiency discovery program at the 6th World Congress on Targeting Mitochondria in Berlin, Germany.
Help employers find you! Check out all the jobs and post your resume.
